Roche Says Indonesia Can Make Tamiflu
Roche Holding Ltd. said Indonesia could make a generic version of Tamiflu without its license because the medicine, which may be useful in treating avian influenza, isn’t protected by a patent in the Southeast Asian nation.
“We’ve informed the government they can produce it for local use,” said Martina Rupp, a spokeswoman for the Swiss drug maker. “Quality guidelines will have to be assured by the Indonesian government.”
The move will help Indonesia prepare for a possible outbreak of avian influenza among humans. The government could ask state-owned PT Kimia Farma or PT Indofarma to make the medicine, Indonesian Health Minister Siti Fadilah Supari said.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
